Industry NewsSherlock Biosciences announces initial results of automation study with NorDx Laboratories on CRISPR-based test for SARS-CoV-2
Industry NewsSherlock Biosciences announces discovery of novel CRISPR-Cas enzymes, enabling simple multiplex diagnostic solutions
Industry NewsSherlock Biosciences announces clinical data from study of Sherlock CRISPR SARS-CoV-2 Kit
Product NewsSherlock Biosciences, binx health partner to develop first CRISPR-based point-of-care test for COVID-19
